Elevance Health, Inc. (ELV)
Can Carelon Drive Elevance Health's Future Earnings Growth?
Carelon is becoming a major growth driver for ELV, boosting revenues, care efficiency and long-term earnings potential despite near-term investment pressure.
ELV Accelerates Clinical Reviews Through Health OS Platform
Elevance Health's Health OS is cutting review delays and admin work, with early results showing fewer denials and holds as digital healthcare adoption expands.
Elevance Health (ELV) Upgraded to Buy: Here's What You Should Know
Elevance Health (ELV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Elevance Tops $1B in Housing Investments: What's Driving the Strategy?
ELV surpasses $1B in affordable housing investments, aiming to improve health outcomes, expand care access and support long-term growth.
Elevance Health: Making The Bull Case For Ongoing Recovery (Rating Upgrade)
Elevance Health, Inc. has rebounded ~34% from its March lows, supported by sector recovery and improved Q1 2026 results. Q1 2026 saw ELV revenue up 1.5% to $49.5bn, adjusted EPS up 5.1% to $12.58, and a benefit expense ratio improvement to 86.8%. ELV raised 2026 adjusted EPS guidance to at least $26.75 and expects a return to 12% adjusted EPS growth in 2027.
Elevance Health (ELV) Up 12.6% Since Last Earnings Report: Can It Continue?
Elevance Health (ELV) reported earnings 30 days ago. What's next for the stock?
Elevance Health, Inc. (ELV) Shareholder/Analyst Call Prepared Remarks Transcript
Elevance Health, Inc. (ELV) Shareholder/Analyst Call Prepared Remarks Transcript
ELV Beats Q1 Earnings Estimates on Rising Net Investment Income
Elevance Health beats Q1 EPS estimates as net investment income jumps 29.7%, offsetting membership decline and higher expenses.
Elevance Health, Inc. (ELV) Q1 2026 Earnings Call Transcript
Elevance Health, Inc. (ELV) Q1 2026 Earnings Call Transcript
Here's What Key Metrics Tell Us About Elevance Health (ELV) Q1 Earnings
While the top- and bottom-line numbers for Elevance Health (ELV) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Elevance Health (ELV) Surpasses Q1 Earnings and Revenue Estimates
Elevance Health (ELV) came out with quarterly earnings of $12.58 per share, beating the Zacks Consensus Estimate of $10.68 per share. This compares to earnings of $11.97 per share a year ago.
Elevance Health Profits Eclipse $1.7 Billion Despite Elevated Costs
Elevance Health Wednesday reported nearly $1.8 billion in first quarter net income as costs continued to be a drag on earnings of the nation's second-largest health insurance company.
